HOMEX-HF-P: Cardiovascular Effects of Preferred Home-based Exercise Training in Systolic Heart Failure

Sponsor
University Medicine Greifswald (Other)
Overall Status
Recruiting
CT.gov ID
NCT02051712
Collaborator
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) (Other)
120
1
3
106
1.1

Study Details

Study Description

Brief Summary

The aim of the study is I. To assess whether an individualized exercise training program is superior as compared to usual care with respect to exercise tolerance, II. to assess whether intervention tools that aim to increase exercise adherence are superior to an individualized exercise training alone with respect to exercise tolerance and long-term effects, and III. to identify biomarkers that that may be implemented into novel intervention tools aiming to increase exercise adherence in patients with chronic heart failure.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: exercise training
  • Behavioral: Adherence measures
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Cardiovascular Effects of Preferred Home-based Exercise Training and Extended Adherence Measures in Systolic Heart Failure - Pilot Study
Study Start Date :
Feb 1, 2014
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual care

Usual car accruing to guidelines

Experimental: Individualized training

Individualized exercise training program in addition to usual care

Behavioral: exercise training
individualized exercise training

Experimental: Individualized training plus adherence measures

Individualized exercise training plus measures to increase adherence

Behavioral: exercise training
individualized exercise training

Behavioral: Adherence measures
Measures to increase adherence to exercise training

Outcome Measures

Primary Outcome Measures

  1. VO2@AT [Month 9]

    Change of cardiopulmonary exercise tolerance from baseline to 9 month follow-up measured by exercise testing: oxygen uptake at anaerobic threshold per kg body weight (METs)

Secondary Outcome Measures

  1. Training adherence [9, 12, 18 and 24 month]

    Adherence to training sessions

Other Outcome Measures

  1. AE [9, 12, 18 and 24 month]

    Adverse events, related and unrelated to exercise training

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • women and men

  • age 30-75 years

  • chronic heart failure (NYHA II/III), left ventricular ejection fraction ≤40% be echo

  • disease duration ≥ 6 month

  • medical therapy accruing to guidelines (drug, devices, including CRT)

  • written informed consent

Exclusion Criteria:
  • acute myocarditis

  • instable angina

  • heart surgery (e.g. ICD implantation, bypass) with last 6 weeks; CRT implantation within the last 6 months before study start

  • severe cardiovascular events (myocardial infarction, cardiac decompensation, ICD shock, PCI due to instable angina) < 6 weeks before study start

  • preplanned hospital admission or intervention (e.g. planned revascularization, ICD implantation)

  • uncorrected valve regurgitation or stenosis (> second degree)

  • safety concerns regarding or other reasons against exercise training

  • severe depression

  • regular exercise training within the last 6 weeks

  • life expectancy < 1 year

Contacts and Locations

Locations

Site City State Country Postal Code
1 Marcus Dörr Greifswald Germany 17475

Sponsors and Collaborators

  • University Medicine Greifswald
  • Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

Investigators

  • Principal Investigator: Marcus Dörr, MD, University Greifswald

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Medicine Greifswald
ClinicalTrials.gov Identifier:
NCT02051712
Other Study ID Numbers:
  • DZHK-HGW-001
First Posted:
Jan 31, 2014
Last Update Posted:
Oct 1, 2021
Last Verified:
Sep 1, 2021
Keywords provided by University Medicine Greifswald
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 1, 2021